Table 1. Ion channel gene expression in NSCs with and without amiodarone HCl treatment compared to similarly treated dopaminergic neurons.

Category	Gene	Treated NSC	Untreated NSC	Treated DA Neuron	Untreated DA Neuron
H ion transporters	ATP6V1A	1155.9	1093.8	2621.5	2441.8
	ATP6V1B2	385.4	331	724.8	438.2
	ATP6V0D1	3355	2760.4	2920.7	2452.5
	ATP5B	7030.3	5745.1	5217.1	4313.4
	ATP6V0A2	190.2	163	131.3	108
	SLC2A11	22.8	31.1	.9	34.9
	SLC35B1	1769.8	1380.4	1450.4	1122.8
	SLC2A1	1274.8	1574.5	87.1	86.7
Amine transporters	SLC1A2	15.7	21.3	809.7	681
	SLC1A3	552.1	433.5	2926	2578.1
	SLC6A3	−1.2	4.8	−3.4	10.5
	SLC6A9	329.2	251.5	36570.5	489.3
	SLC6A12	9.6	7.4	10.8	10.4
	ATP1A1	586.9	615.7	426.9	341.4
	ATP1A1	786.4	725.1	471	399.4
Cl channels	CLCN6	349.8	311.8	998.5	745.9
	CLCN7	1305.5	903.2	1261	1058.4
	CLCN3	566.5	440.4	541.2	497.2
	CLCN2	41.6	30.2	24	21.7
	CLIC1	122.2	94.9	22.9	18
Voltage gated Na channels	SCN9A	1.9	2.6	245.7	175.1
	SCN1A	−0.5	7.6	115.6	110.2
	SCN3A	5.7	6.3	60.4	72.3
Amiloride sensitive Na channels	ACCN1	16.5	15.4	387.4	360.1
	ACCN3	11	5.1	35.7	38.1
	ACCN2	185.7	167.4	862.7	837.1
Rectifier K channels	KCND2	2.3	8.9	269.9	225.5
	KCNQ2	138.1	137	1753.5	1378.2
	KCNC4	4.5	5.8	58.7	38.7
	KCNJ4	15.9	11.6	66.1	64.3
	KCNQ3	3.4	5.5	23.2	25.4
	KCNG1	150.4	92.7	351	365
	KCNF1	189.2	152	479.7	457.6
	KCNJ11	13.5	17.7	44.4	26.5
	KCNJ6	317.3	271.5	297.7	256.7
	KCNQ2	919.6	796.2	434.4	420.4
Delayed rectifier K channels	KCNA5	−4.2	0.4	99.9	84
	KCNS1	5.2	2.2	20.3	39.9
	KCNH2	25.6	32	165.6	151.9
	KCNB1	32.8	34.2	145.4	111.5
	KCNB2	25	28.7	94.5	79.1
	KCNH2	11.2	5.8	21	14.2
Ca activated K channels	KCNN1	6.5	0.6	48.4	28.9
	KCNN3	0.7	6.3	181.7	127.1
	KCNN2	15.8	12.3	55.6	50.1
	KCNMB1	62.9	60.4	44.8	72.6
Calcium channels	CACNB2	7.8	12	155.2	156.9
	CACNG2	2.5	11.5	123.8	115.6
	CACNA1A	2	10.1	64.4	62.6
	CACNA1C	25.9	29.3	146.9	138.8
	CACNA1H	122.7	87.8	268.9	220.4